Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DIBI, a 3-hydroxypyridin-4-one chelator iron-binding polymer with enhanced antimicrobial activity
M. Trisha C. Ang, Roger Gumbau‐Brisa, David Allan, et al.
MedChemComm (2018) Vol. 9, Iss. 7, pp. 1206-1212
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

The role of quorum sensing, biofilm formation, and iron acquisition as key virulence mechanisms in Acinetobacter baumannii and the corresponding anti-virulence strategies
Soffi Kei Kei Law, Hock Siew Tan
Microbiological Research (2022) Vol. 260, pp. 127032-127032
Open Access | Times Cited: 45
Iron Metabolism at the Interface between Host and Pathogen: From Nutritional Immunity to Antibacterial Development
Marialaura Marchetti, Omar De Bei, Stefano Bettati, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 2145-2145
Open Access | Times Cited: 68
Recent Advances in Iron Chelation and Gallium-Based Therapies for Antibiotic Resistant Bacterial Infections
Víctor Vinuesa, Michael J. McConnell
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 6, pp. 2876-2876
Open Access | Times Cited: 50
The Emerging Role of Ferroptosis in Sepsis
Yanting Liu, Sichuang Tan, Yongbin Wu, et al.
DNA and Cell Biology (2022) Vol. 41, Iss. 4, pp. 368-380
Closed Access | Times Cited: 33
Hydroxypyridinone-Based Iron Chelators with Broad-Ranging Biological Activities
Xiaoying Jiang, Tao Zhou, Renren Bai, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 23, pp. 14470-14501
Closed Access | Times Cited: 41
Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities
Usama Abbasi, Srinivas Abbina, Arshdeep Gill, et al.
ACS Chemical Biology (2021) Vol. 16, Iss. 6, pp. 945-972
Closed Access | Times Cited: 38
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?
Giovanni Stelitano, Mario Cocorullo, Matteo Mori, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6181-6181
Open Access | Times Cited: 14
Novel Iron-Chelator DIBI Inhibits Staphylococcus aureus Growth, Suppresses Experimental MRSA Infection in Mice and Enhances the Activities of Diverse Antibiotics in vitro
Maria del Carmen Parquet, Kimberley A. Savage, David Allan, et al.
Frontiers in Microbiology (2018) Vol. 9
Open Access | Times Cited: 39
Recent Advances in the Synthesis of Complex Macromolecular Architectures Based on Poly(N-vinyl pyrrolidone) and the RAFT Polymerization Technique
Νικολέττα Ρόκα, Olga Kokkorogianni, Philippos Kontoes-Georgoudakis, et al.
Polymers (2022) Vol. 14, Iss. 4, pp. 701-701
Open Access | Times Cited: 22
Methicillin-resistant Staphylococcus pseudintermedius: epidemiological changes, antibiotic resistance, and alternative therapeutic strategies
Francesca Paola Nocera, Luisa De Martino
Veterinary Research Communications (2024) Vol. 48, Iss. 6, pp. 3505-3515
Open Access | Times Cited: 4
Antibiotic-Resistant Acinetobacter baumannii Is Susceptible to the Novel Iron-Sequestering Anti-infective DIBI In Vitro and in Experimental Pneumonia in Mice
Maria del Carmen Parquet, Kimberley A. Savage, David Allan, et al.
Antimicrobial Agents and Chemotherapy (2019) Vol. 63, Iss. 9
Open Access | Times Cited: 26
Nutrient Limitation Sensitizes Pseudomonas aeruginosa to Vancomycin
Derek C. K. Chan, Katherine Dykema, Mahrukh Fatima, et al.
ACS Infectious Diseases (2023) Vol. 9, Iss. 7, pp. 1408-1423
Closed Access | Times Cited: 9
Iron-withdrawing anti-infectives for new host-directed therapies based on iron dependence, the Achilles’ heel of antibiotic-resistant microbes
Bruce E. Holbein, M. Trisha C. Ang, David Allan, et al.
Environmental Chemistry Letters (2021) Vol. 19, Iss. 4, pp. 2789-2808
Open Access | Times Cited: 18
Potential Mechanisms of Mucin-Enhanced Acinetobacter baumannii Virulence in the Mouse Model of Intraperitoneal Infection
Greg Harris, Bruce E. Holbein, Hongyan Zhou, et al.
Infection and Immunity (2019) Vol. 87, Iss. 11
Open Access | Times Cited: 18
Chelators for Treatment of Iron and Copper Overload: Shift from Low-Molecular-Weight Compounds to Polymers
Martin Hrubý, Ivette Santana-Martínez, Holger Stephan, et al.
Polymers (2021) Vol. 13, Iss. 22, pp. 3969-3969
Open Access | Times Cited: 16
Iron Chelation in Murine Models of Systemic Inflammation Induced by Gram-Positive and Gram-Negative Toxins
Danielle Fokam, Kayle Dickson, Kiyana Kamali, et al.
Antibiotics (2020) Vol. 9, Iss. 6, pp. 283-283
Open Access | Times Cited: 15
Iron Chelation as a Potential Therapeutic Approach in Acute Lung Injury
Xiyang Zhang, Juan Zhou, Bruce E. Holbein, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1659-1659
Open Access | Times Cited: 5
The influence of linkages between 1-hydroxy-2(1H)-pyridinone coordinating groups and a tris(2-aminoethyl)amine core in a novel series of synthetic hexadentate iron(III) chelators on antimicrobial activity
David G. Workman, Michael Hunter, Shuning Wang, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103465-103465
Open Access | Times Cited: 15
Hydroxypyridinone-Based Metal Chelators towards Ecotoxicity: Remediation and Biological Mechanisms
M. Amélia Santos, Anna Irto, Péter Buglyó, et al.
Molecules (2022) Vol. 27, Iss. 6, pp. 1966-1966
Open Access | Times Cited: 9
Iron Chelator DIBI Suppresses Formation of Ciprofloxacin-Induced Antibiotic Resistance in Staphylococcus aureus
David Allan, Bruce E. Holbein
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1642-1642
Open Access | Times Cited: 8
Iron Sequestrant DIBI, a Potential Alternative for Nares Decolonization of Methicillin-Resistant Staphylococcus aureus, Is Anti-infective and Inhibitory for Mupirocin-Resistant Isolates
David Allan, Maria del Carmen Parquet, Kimberley A. Savage, et al.
Antimicrobial Agents and Chemotherapy (2020) Vol. 64, Iss. 3
Open Access | Times Cited: 11
Antimicrobial Activity of the Iron-Chelator, DIBI, against Multidrug-Resistant Canine Methicillin-Susceptible Staphylococcus pseudintermedius: A Preliminary Study of Four Clinical Strains
Francesca Paola Nocera, Giuseppe Iovane, Luisa De Martino, et al.
Pathogens (2022) Vol. 11, Iss. 6, pp. 656-656
Open Access | Times Cited: 7
The Iron Chelator, DIBI, Reduces Bacterial Load and Inflammation in Experimental Lung Infection
Xiyang Zhang, Rhea Nickerson, Lauren Burton, et al.
(2024)
Open Access | Times Cited: 1
Iron metabolismin conditions of infection. Review
Yu. P. Orlov, Н. В. Говорова, В Н Лукач, et al.
Annals of critical care (2020), Iss. 1, pp. 90-99
Open Access | Times Cited: 10
Polyglycerol-Based Macromolecular Iron Chelator Adjuvants for Antibiotics To Treat Drug-Resistant Bacteria
Srinivas Abbina, Arshdeep Gill, Snehamol Mathew, et al.
ACS Applied Materials & Interfaces (2020) Vol. 12, Iss. 34, pp. 37834-37844
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top